These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1653 related articles for article (PubMed ID: 35113855)

  • 1. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
    Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
    Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the causal relationship between antihypertensive drugs and glioblastoma by combining drug target Mendelian randomization study, eQTL colocalization, and single-cell RNA sequencing.
    Zhao S; Xie Y; Ding X; Zheng C; Chen J; Zhao N; Ji Y; Wang Q; Liu Y; Cheng C
    Environ Toxicol; 2024 Jun; 39(6):3425-3433. PubMed ID: 38450887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
    Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
    BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study.
    Chauquet S; Zhu Z; O'Donovan MC; Walters JTR; Wray NR; Shah S
    JAMA Psychiatry; 2021 Jun; 78(6):623-631. PubMed ID: 33688928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of mendelian randomization for investigating drug effects.
    Gill D; Burgess S
    PLoS Med; 2022 Feb; 19(2):e1003898. PubMed ID: 35113864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.
    Liu H; Zuo H; Johanna O; Zhao R; Yang P; Chen W; Li Q; Lin X; Zhou Y; Liu J
    Eur Stroke J; 2024 Mar; 9(1):244-250. PubMed ID: 37800876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
    Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
    Elife; 2022 Mar; 11():. PubMed ID: 35346416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study.
    Yuan S; Burgess S; Laffan M; Mason AM; Dichgans M; Gill D; Larsson SC
    J Am Heart Assoc; 2021 Apr; 10(8):e019644. PubMed ID: 33834859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
    Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
    Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
    Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
    Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.
    Wang Z; Lu J; Hu J
    Liver Int; 2023 Jun; 43(6):1320-1331. PubMed ID: 37005366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
    Fan B; Zhao JV
    BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive Drugs for the Prevention of Atrial Fibrillation: A Drug Target Mendelian Randomization Study.
    Geurts S; Tilly MJ; Lu Z; Stricker BHC; Deckers JW; de Groot NMS; Miller CL; Ikram MA; Kavousi M
    Hypertension; 2024 Aug; 81(8):1766-1775. PubMed ID: 39018378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
    Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
    J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study.
    Larsson SC; Mason AM; Kar S; Vithayathil M; Carter P; Baron JA; Michaëlsson K; Burgess S
    BMC Med; 2020 Dec; 18(1):370. PubMed ID: 33261611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.